ABSTRACT Background: Dietary glycemic index and load are widely used to estimate the effect of carbohydrate-containing foods on postprandial blood glucose concentrations and as surrogates for insulin response. The food insulin index (II) directly quantifies the postprandial insulin secretion of a food and takes into account foods with a low or no carbohydrate content. Objective: We investigated the average dietary II and insulin load (IL) in relation to biomarkers of glycemic control, plasma lipids, and inflammation markers. Design: In a cross-sectional setting and with the use of data from the Nurses' Health Study and the Health Professionals Follow-Up Study, we measured plasma concentrations of C-peptide, glycated hemoglobin (Hb A 1c ), HDL cholesterol, LDL cholesterol, triglycerides, C-reactive protein (CRP), and interleukin-6 (IL-6) in fasting blood samples of 4002 healthy men and women. The dietary II and IL were assessed from food-frequency questionnaires by using directly analyzed or published food II data. Results: After multivariate adjustment, participants in the highest quintile of II had 26% higher triglyceride concentrations than did participants in the lowest quintile of II (P for trend , 0.0001). This association was strongest in obese [body mass index (in kg/m 2 ) 30] participants (difference between highest and lowest quintiles in the II: 72%; P for trend = 0.01). Dietary II was inversely associated with HDL cholesterol in obese participants (difference: 218%; P for trend = 0.03). Similar associations were seen for the IL. Dietary II and IL were not significantly associated with plasma C-peptide, Hb A 1c , LDL cholesterol, CRP, or IL-6. Conclusion: Dietary II and IL were not associated with fasting biomarkers of glycemic control but may be physiologically relevant to plasma lipids, especially in obese individuals.
INTRODUCTION
The ability of foods to induce postprandial insulin secretion may be relevant in the context of the prevention and management of weight gain, hyperlipidemia, and type 2 diabetes. In addition, a long-term exposure to high insulin concentrations may be associated with increased risk of cancer (1) .
The insulinogenic effect of foods is most commonly estimated by the glycemic index (GI). The GI is a concept to rank carbohydrate-containing foods according to their ability to raise blood glucose concentrations postprandially compared with a reference food of either glucose or white bread (2) . However, the blood glucose response is not always proportional to the insulin response (3) . Although carbohydrates are the major stimulus for insulin secretion, other dietary factors also play a role. Foods high in protein or fat provoke a significant insulin response, and proteins synergistically enhance the insulin response to carbohydratecontaining foods (3) .
A food insulin index (II) has been suggested, which directly quantifies the postprandial insulin response to a test food in comparison with an isoenergetic portion of a reference food (analogous to the GI, either glucose or white bread) (3, 4) . Because the measure of comparison is energy as opposed to carbohydrates for the GI, the II concept allows for the testing of foods with no or a low carbohydrate content. The II has been shown to predict the relative insulin demand evoked by mixed meals (4) .
In epidemiologic studies, because the II is directly based on the insulin response, it may be more suitable to examine hypotheses that link insulin exposure with the development of chronic diseases than to use dietary surrogate measures for the insulin response such as GI, glycemic load (GL), or total carbohydrate intake. On the basis of the II of individual foods, the overall insulin load (IL) and average II of a diet can be estimated. The physiologic relevance of the II concept in large populations as well as the ability of dietary assessment instruments commonly used in epidemiologic studies to validly estimate the II and IL remain to be elucidated. The purpose of the current study was to estimate the cross-sectional association of the II and IL estimated from food-frequency questionnaires (FFQs) with biomarkers of glycemic control, plasma lipids, and inflammation markers, with the hypothesis that a high dietary II or IL may be associated with unfavorable patterns of these markers (ie, high concentrations of plasma C-peptide, LDL, triglycerides, and inflammation markers and low concentrations of HDL).
SUBJECTS AND METHODS

Health Professionals Follow-Up Study
The Health Professionals Follow-Up Study (HPFS) is a prospective cohort study that was initiated in 1986 when 51,529 male health professionals aged between 40 and 75 y completed a detailed self-administered FFQ and medical history questionnaire. Since then, participants have been followed by means of biennial questionnaires that ascertain updated information on lifestyle factors as well as new medical diagnoses. Dietary FFQs have been completed by the participants every 4 y. Between 1993 and 1995, participants were invited to provide a blood sample, which was returned by 18,225 participants. Blood samples were collected in tubes containing liquid EDTA and returned to the laboratory on ice via an overnight courier. On the basis of the selfreported information on the time since the last meal at blood collection, 61% of blood samples were considered fasting (9 h since the last meal). In this analysis, 1572 HPFS participants who provided fasting blood samples were included; participants were either control subjects in prostate cancer, colon cancer, or myocardial infarction case-control studies or healthy men who were randomly selected on the basis of their alcohol-consumption patterns for a study on the association between alcohol-drinking patterns and novel biomarkers of ischemic heart disease (5).
Nurses' Health Study
The Nurses' Health Study (NHS) cohort, established in 1976, comprises 121,700 female registered nurses aged between 30 and 55 y who answered a mailed questionnaire about their medical histories and lifestyles. Participants have been followed up every 2 y to assess lifestyle factors and incident diseases. Dietary intakes were assessed by means of FFQs in 1980 FFQs in , 1984 FFQs in , and 1986 and every 4 y afterward. In 1989 and 1990, blood samples were provided by 32,826 participants. The blood samples were shipped on an ice packs via overnight mail. In participants who provided blood samples, 65% of participants reported to have been fasting for 9 h at the time of the blood draw. In total, 2430 cohort members who provided fasting blood samples were included in this analysis, all of whom were control participants in casecontrol studies on diabetes, myocardial infarction, hypertension, breast cancer, colorectal cancer, and colorectal polyps.
With the combination of data from the HPFS and NHS, a total of 4002 healthy participants were included in the analysis. None of the men or women included had been previously diagnosed with cancer, cardiovascular disease, or diabetes at the time of blood collection. A comparison of participants who provided blood samples (27% of participants in the NHS and 36% of participants in the HPFS) with those who did not suggested that the participants did not differ substantially with regard to potential confounders in this study [ie, age, body mass index (BMI), and dietary intake assessed in the year of blood collection], although participants who gave blood were less likely to be current smokers and slightly more physically active, both of which we accounted for in the statistical models (see Statistics). The study was approved by the Institutional Review Board of Harvard School of Public Health and Brigham and Women's Hospital (Boston, MA).
Measurement of biomarkers
After the receipt of mailed blood samples, samples were centrifuged, divided, and subsequently stored in liquid nitrogen (2150°C) until analysis. Fasting concentrations of plasma Cpeptide were measured by enzyme-linked immunosorbent assay and a radioimmunoassay method, as previously described (6) . Red blood cell glycated hemoglobin (Hb A 1c ) was measured by a temperature-controlled HPLC method (5) . Concentrations of total, HDL, and directly obtained LDL cholesterol and triglycerides were measured by standard methods with reagents from Roche Diagnostics (Indianapolis, IN) and Genzyme (Cambridge, MA) (7, 8) . C-reactive protein (CRP) was measured by means of a highly sensitive immunoturbidimetric assay with reagents and calibrators from Denka Seiken (Niigata, Japan). Interleukin-6 (IL-6) was measured by using enzyme-linked immunosorbent assays (R&D Systems, Minneapolis, MN). Plasma insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein (IGFBP)-1 and -3 concentrations were measured by enzyme-linked immunosorbent assays (Diagnostic Systems Laboratory, Webster, TX) in the laboratory of Michael Pollak (McGill University, Montreal, Canada), as previously described (9) . CVs for all assays were ,11%.
Dietary assessment
In both the HPFS and NHS, dietary intakes were assessed by means of a validated semiquantitative 131-item FFQ, which has been previously described (10, 11) . The FFQ was designed to quantify the average food intake during the previous year. Participants were asked to report how often, on average, they consumed a specified serving of each food item with 9 possible response categories that ranged from never or less than once per month to 6 times per day. Daily nutrient intakes were calculated from FFQ data by multiplying the nutrient content per serving of each food by the indicated frequency of consumption (servings of that food per day) and summing over all foods.
II and IL
The dietary II is based on a concept comparable with the GI. Although the GI of a food is based on the glucose response (2), the II directly quantifies the insulin secretion in response to the consumption of a certain food. Formally, the II refers to the incremental insulin area under the curve over 2 h in response to the consumption of a 1000-kJ portion of the test food divided by the area under the curve after ingestion of a 1000-kJ portion of the reference food. Analytic data on the food II of FFQ items (with glucose as the reference food) were provided by JC Brand-Miller (University of Sydney, Sydney, Australia) by either direct testing or from published estimates (3, 12) . Various US food samples, which were selected to be representative for FFQ items, were shipped for analysis to the laboratory in Sydney, Australia. The testing procedure has been described previously (3) . Test subjects consumed various test foods on separate days, and during the 2 h after consumption, their blood insulin concentrations were measured every 15 min. Individual II values were based on the average values of 11-13 test subjects. FFQ items were assigned II values on the basis of direct analysis (30%), published data (14%) (3, 12) , recipe-derived data, or imputing values (the remaining FFQ items).
For the present study, the individual average IL (IL ave ) during the past year was estimated from FFQs by multiplying the II of each food by its energy content and the consumption frequency and summing over all reported food items as follows
where n is the number of foods consumed, II a is the II for food a, Energy a is the energy content per serving of food a, and Frequency a is the consumption frequency of one serving of food a during the past 12 mo. Each unit of IL represented energy equivalents from glucose. The average dietary II (II ave ) was calculated by dividing the average IL by the total energy intake as follows
where n is the number of foods consumed, FII a is the II of food a, Energy a is the energy content of food a, and Frequency a is the daily consumption frequency of one serving of food a during the past 12 mo.
Statistical analyses
Because inflammatory markers can be heavily influenced by acute states (eg, infections) at the time of the blood collection, we excluded participants with extremely high (mean + 2 SDs) concentrations of CRP (n = 28) and IL-6 (n = 13) from the analysis. The total study population comprised all participants who had a measured concentration of at least one of the biomarkers under investigation (n = 4002). The numbers of participants included in the individual biomarker analyses were as follows: C-peptide, n = 2748; Hb A 1c , n = 735; LDL, n = 991; HDL, n = 1328; cholesterol, n = 1325; triglycerides, n = 994; IGF-I, n = 2001; IGFBP-3, n = 2011; IGFBP-1, n = 1671; CRP, n = 1472; and IL-6, n = 899. In both studies, we used the dietary and covariate assessment, which was closest to the year of the blood collection (ie, data from the 1994 questionnaire in the HPFS and the 1990 questionnaire in the NHS. Dietary insulin load was adjusted for total energy intake by means of the residual method (13) and standardized to an energy intake of 2000 kcal in men and 1600 kcal in women. We used multivariate linear regression with robust variance (PROC MIXED with empirical statement, version 9.1; SAS Institute, Cary, NC) (14) to investigate the association between dietary II or IL and plasma concentrations of C-peptide, Hb A 1c , total cholesterol, HDL, LDL, triglycerides, CRP, IL-6, IGF-I, and IGFBP-1 and -3. This method allowed for valid inference without the assumption of normal distribution in the dependent variable. However, to improve the model fit, we log transformed concentrations of C-peptide, triglycerides, CRP, IL-6, and IGFBP-1 because their distributions were heavily skewed. Multivariate-adjusted mean concentrations and corresponding 95% CIs were estimated by the least-squares means method in quintiles of II or IL, respectively. The means of the log-transformed biomarkers are presented as geometric means. Relative differences in mean biomarker concentrations between quintiles were calculated. To test for a linear trend, participants were assigned median values of II or IL quintiles, and this variable was entered as a continuous term in the models (P values for the linear trend derived from Wald's test for this variable). To account for multiple testing, we applied a Bonferroni correction on the basis of the number of analyzed biomarkers and tested covariates. Statistical significance was assumed if P , a c (Bonferroni-corrected a).
Initially, analyses were conducted separately in the 2 studies, with adjustment for a variety of confounders including sexspecific variables (eg, menopausal status and postmenopausal hormone use in the NHS) and analysis batch. Subsequently, when study-specific associations were similar, we combined the data of the 2 studies. We tested for an interaction by study by using a cross-product term of study and the II or IL (trend variables). Only combined models are presented because no significant interaction by study (all P values for interaction . 0.05) was observed. We present 2 different adjustment models. Model 1 was minimally adjusted for study and sex, age at blood collection, BMI (in kg/m 2 ) at blood collection (continuous), and energy intake (kcal, quintiles); model 2 was additionally adjusted for the prevalence of high blood pressure (yes or no), prevalence of high blood cholesterol (yes or no), physical activity (metabolic equivalent tasks per week, quintiles), smoking status at blood collection (never, past, or current), and alcohol intake (0, 0.1-4.9, 5-14.9, 15-29.9, and 30 g/d). Because we anticipated that the effect of the II and IL on certain biomarkers might be different depending on the body fatness of participants, we stratified analyses for C-peptide, LDL, HDL, triglycerides, and IGFBP-1 by BMI (,25, 25-29.9, and 30). We tested for a statistical interaction by creating a cross-product term of median values of BMI in 3 categories and dietary II or IL (trend variable) and checked its Wald-test P value in a model with the main effects and the cross-product term. Because certain biomarkers such as IGFBP-1 and HDL are influenced by alcohol intake and some alcoholic beverages have exceptionally low II values, we additionally stratified models by drinking behavior ([ie individuals who reported no alcohol intake in the FFQ (nondrinkers) compared with individuals who reported any consumption of alcohol (drinkers)]. To avoid residual confounding by the amount of alcohol consumed in the group of drinkers, we additionally adjusted for categories of alcohol intake (0.1-4.9, 5-14.9, 15-29.9, and 30 g/d). Tests for interaction by drinking status were performed by using cross-product terms.
RESULTS
Median dietary II was 41.7 (5th-95th percentile range: 32.3-50.0) in men and 42.8 (5th-95th percentile range: 34.6-50.7) in women. Median IL was 840 (5th-95th percentile range: 651-1013) in men and 677 (5th-95th percentile range: 551-810) in women. In women, the top 10 FFQ items that contributed to insulin loads were mashed potatoes (6.2% contribution), skimmed milk (5.7%), cold cereal (5.3%), dark bread (4.6%), beef (3.6%), yogurt (3.3%), white bread (3.1%), English muffins (2.7%), pizza (2.6%), and bananas (2.6%). In men, these items were cold cereal (6.1% contribution), potatoes (5.7%), dark bread (4.4%), skimmed milk (3.2%), bananas (3.2%), English muffins (3.1%), white bread (2.9%), orange juice (2.8%), and pizza (2.7%). The top 4 FFQ items that explained the interindividual variation of insulin loads in the NHS were liquor, wine, yogurt, and cold cereal. Together, these items explained 45% of interindividual variation, whereas liquor and wine were inversely associated with insulin load (negative variable estimates), and yogurt and cold cereal were positively associated with insulin loads. In the HPFS, liquor, cold cereal, beer, and white wine together explained 49% of the interindividual variation; again, liquor, beer, and white wine were inversely associated with insulin load and cold cereal was positively associated with insulin load.
In the NHS and HPFS, participants in the upper quintiles of the II and IL were slightly older than participants in the lower quintiles ( Table 1) . NHS and HPFS participants with a higher II and IL were less likely to be current smokers. Neither height nor BMI differed by II or IL. Dietary II and IL were strongly inversely associated with alcohol intakes. In the upper quintiles of II and IL, the percentage of energy from fat was lower, whereas the percentage of energy from carbohydrates was higher, than in the lower quintiles. In both studies, dietary II and IL were positively associated with the GI and GL. Spearman's r was 0.39 (P , 0.0001) between the II and GI and 0.81 (P , 0.0001) between the IL and GL in the total study population.
The minimally (sex, age-, BMI-, and energy-adjusted) and fully multivariate-adjusted mean biomarker concentrations by quintiles of the II and IL in the combined study population are shown in Table 2 . In the multivariate-adjusted models, the II and IL were not significantly associated with plasma C-peptide. In the minimally adjusted model, mean plasma C-peptide concentration was significantly lower in the upper quintiles of II than in the lower quintiles of the II. The dietary II or IL was not significantly associated with Hb A 1c , plasma LDL, or total cholesterol. In the minimally adjusted model, mean concentrations of HDL cholesterol were significantly decreasing across quintiles of II and IL, although this inverse association did not persist after the full multivariate adjustment. Plasma concentrations of triglycerides significantly increased across quintiles of the II and IL in both multivariate-adjustment models. On average, geometric mean triglyceride concentrations were 26% higher in the highest than in the lowest quintile of II. When the GI was added to the model that investigated the association between II and triglycerides, both II and GI were significantly positively associated with triglycerides, although the strength of the association was attenuated [comparing highest with lowest quintiles, the percentage change (P for trend) was 14% (0.03) for the II and 15% (0.03) for the GI]. In contrast, when we adjusted the model on IL and triglycerides for GL, the significant positive association of IL did not persist, and GL was significantly positively associated with triglycerides before and after adjustment for IL (data not shown).
There was no association between II or IL and plasma concentrations of IGF-I or IGFBP-3. Multivariate adjusted geometric mean concentrations of IGFBP-1 increased significantly across quintiles of the II and IL (the P for trend was 0.01 for II and 0.03 for IL). These associations did not appreciably change after additional adjustment for GI or GL (data not shown). No association was observed between II or IL and inflammatory biomarkers CRP or IL-6.
Additional adjustment of multivariate models for the percentage of energy intake from protein or carbohydrates did not substantially change the results for the various biomarkers.
Associations between II and IL and biomarkers that were expected to be influenced by overweight were investigated separately in normal-weight (BMI ,25), overweight (BMI of 25-29.9), and obese (BMI 30) participants. After stratification by body fatness, we did not observe any stratum-specific associations between the dietary II or IL and plasma C-peptide, Hb A 1c or LDL (data not shown). Dietary II was significantly inversely associated with HDL concentrations in obese (P for trend = 0.03) but not in overweight or normal-weight participants ( Figure 1 ) (P for interaction = 0.89). Similarly, an inverse association was observed between dietary IL and HDL concentrations in obese participants only (P for trend = 0.06; data not shown). The dose-response gradient of the positive association between dietary II and triglycerides increased across BMI categories (Figure 2) , although no statistical interaction was observed (P for interaction = 0.27). A particularly strong positive association between dietary II and triglyceride concentrations was observed in obese participants. For the lowest to highest quintiles of dietary II, the multivariate-adjusted geometric mean triglyceride concentrations were 86 and 103 mg/dL in normal-weight, 117 and 140 mg/dL in overweight, and 134 and 231 mg/dL in obese participants. Similar associations and increasing dose-response gradients were observed between IL and triglyceride concentrations after stratification by BMI categories (data not shown). After additional adjustment for GI or GL, although attenuated, nonsignificant positive associations between II/IL and serum triglycerides persisted in all 3 BMI subgroups (data not shown). After stratification by BMI categories, no significant positive associations between II/IL and IGFBP-1 were observed. For the lowest to the highest quintiles of dietary II, the multivariate-adjusted geometric mean IGFBP-1 concentrations were 27.5 and 30.1 ng/mL in normal-weight, 15.3 and 16.8 ng/mL in overweight, and 8.6 and 11.0 ng/mL in obese participants. BMI-stratified results were similar for the association between the IL and IGFBP-1 concentrations (data not shown). We also observed a significant interaction by drinking status for the association between II and IGFBP-1 (P for interaction = 0.02). The dietary II was significantly positively associated with IGFBP-1 only in drinkers (n = 1111; P for trend , 0.0001), but not in nondrinkers (n = 517; P for trend = 0.89).
DISCUSSION
In this cross-sectional study of healthy men and women, in multivariate adjusted models, the dietary II and IL were not significantly associated with markers of glycemic control such as plasma C-peptide or Hb A 1c . We observed a significant positive association between the II and IL and plasma triglycerides in the total study population, which, after stratification by BMI categories, increased with higher body fatness. In obese individuals, the dietary II and IL were significantly associated with lower HDL concentrations. There was an unexpected positive association between both the II and IL and IGFBP-1, which, however, was not observed after stratification by BMI categories or in participants who did not drink alcohol. We observed no association between the II or IL and inflammatory markers CRP or IL-6.
TABLE 1
Characteristics according to quintiles (Q) of the daily average insulin index and insulin load Carbohydrates (% of energy) Adjusted for total energy intake by means of the residual method.
3
Values not age standardized. To our knowledge, this is the first study to relate average dietary II and IL assessed by FFQs to plasma biomarkers. Plasma C-peptide is a more stable biomarker of insulin secretion than is the direct measurement of plasma insulin because C-peptide has a substantially longer half-life than insulin (15) . Dietary GL has been positively associated with plasma C-peptide in the NHS, although significant positive associations were observed only after adjustment for carbohydrate intake (6). In our study, the dietary II and IL were not positively associated with plasma C-peptide, even when models were adjusted for carbohydrate intake. In contrast, an unexpected inverse association was observed, which was significant in the minimally adjusted models. The lack of a positive association between II/IL and fasting C-peptide might indicate that a habitual diet that evokes high postprandial insulin responses does not result in long-term increases in fasting insulin secretion. Alternately, the observed lower C-peptide concentrations in participants who consumed a high II/IL diet may be interpreted as a sign of a declining b cell function, or this observation could represent compensation for a higher postprandial insulin response that was associated with more rapid glucose clearance.
We observed a significant positive association between II/IL and plasma triglycerides. Previous studies have shown that GI or GL positively predict plasma triglycerides (16) (17) (18) . However, in a Dutch study, no association between GI or GL and plasma triglycerides was observed (19) . In our study, pairwise mutual adjustment indicated that II and GI were independently associated with triglyceride concentrations, whereas triglyceride concentrations seem to be more sensitive to GL than to II. Our observation of stronger positive associations between II/IL and plasma HDL and triglycerides in obese participants seems plausible if we assume that an insulinogenic diet increased the insulin secretion as a function of underlying insulin resistance. Differing dose-response gradients by BMI have previously been shown for the association of dietary GL with HDL as well as triglycerides (16) . High carbohydrate intake and low fat intake have been related to higher triglyceride and lower HDL concentrations in controlled feeding studies (20) as well as in cross-sectional analyses (7, 16, 20) . Similar to our observations, an intervention study showed, after 1 y of follow-up, that a low-fat and highcarbohydrate diet was associated with higher triglyceride and lower HDL concentrations, whereas fasting concentrations of insulin, LDL, and total cholesterol were not affected by the dietary intervention (21). 2 Model 1 was adjusted for sex, age at blood collection, BMI at blood collection (continuous), and energy intake (quintiles). 3 Values are geometric means. 4 Model 2 was adjusted for sex, age at blood collection, BMI at blood collection (continuous), prevalence of high blood pressure (yes or no), prevalence of high blood cholesterol (yes or no), physical activity (quintiles), smoking (never, past, or current), energy intake (quintiles), and alcohol intake (5 categories). 5 Values are means. 6 P , 0.002 (significant after Bonferroni correction). 7 Adjusted for total energy intake by means of the residual method. Table 2 (model 2). P = 0.89 for the interaction between BMI and the dietary insulin index. 1 Percentage difference (95% CI) in HDL between highest and lowest quintiles of the insulin index.
The significant positive association between II/IL and IGFBP-1 was counterintuitive, because it has been shown that insulin suppresses the IGFBP-1 expression (22) , and IGFBP-1 is considered a marker of insulin sensitivity (23) . Alcohol intake has been shown to be inversely associated with circulating IGFBP-1 (24). Because we did not observe significant positive associations between II/IL and IGFBP-1 after stratification by BMI categories or in nondrinking individuals, it seems possible that the unexpected positive association in the total study population might have been at least partly due to residual confounding by body fatness, alcohol intake, or both.
We did not observe any association between dietary II/IL and the inflammatory markers CRP or IL-6, which is a stimulant of CRP production. In the Women's Health Study, GI was positively associated with CRP concentrations (25, 26) . It has been suggested that proinflammatory effects of a Western diet characterized by a high GI may be mediated, in part, by hyperglycemia (27) . Because a high II or IL does not necessarily imply postprandial hyperglycemia, our findings seem plausible, although certainly more studies that elucidate these issues are warranted.
The major limitation of this study was that, conceptually, the II is based on the postprandial insulin response, whereas fasting biomarkers of glycemic control such as C-peptide reflect the basal insulin secretion independent of the last meal. Possibly other dietary characteristics such as meal frequency may also play a substantial role in this association, but such characteristics could not be taken into account in our study design. Although previous studies have seen cross-sectional associations between GI, GL, or other dietary factors (5, 6, 28, 29) and plasma C-peptide, associations were generally not strong, and dietary factors explained only some of the interindividual variation. Diet may be a weaker determinant of fasting biomarkers of glycemic control than genetic and lifestyle factors such as obesity and physical activity (22) . Furthermore, residual confounding might have played a role in our study. II and IL were generally associated with a healthier lifestyle such as less current smoking, which might, even after adjustment, have influenced our findings. Alcohol consumption in the highest quintile of II/IL was 7-8 times lower than that in the lowest quintile. This inverse association and the high proportion of interindividual variation explained by alcoholic beverages were due to the very low insulin response evoked by food items that contained alcohol (eg, the food II for white wine was 3.0), which resulted in a low average II in individuals who derive a substantial proportion of their daily energy intake from alcoholic beverages. Regular alcohol consumption has been associated with lower fasting insulin, higher HDL (30) , and lower IGFBP-1 (24) concentrations. Although our models were adjusted for alcohol consumption, residual confounding by alcohol, possibly due to measurement error in alcohol intake, cannot be excluded. However, when we stratified models by drinking status (drinkers compared with nondrinkers), a significant interaction was observed only for IGFBP-1, which suggests that results for all other biomarkers investigated in this study are not heavily influenced by residual confounding by alcohol intake. As a further limitation, it is possible that a substantial proportion of the study participants were prediabetic at the time of blood collection, which, because of a loss of insulin-secreting b cells (31) , might have introduced a bias in our analysis. Finally, the generalizability of our results is limited because our findings are based on 2 cohorts of middle-aged nurses and health professionals of predominantly European descent.
Strengths of the current study include the sample size as well as the ability to investigate associations with fasting blood samples and to adjust for a variety of confounding factors. The dietary assessment by means of FFQs was, in both studies, relatively close to blood collections, but the time span varied (62 y).
In conclusion, the positive association between II/IL and plasma triglycerides as well as the inverse association observed between II and HDL in obese subjects suggest that the II concept has long-term metabolic relevance, especially in individuals with a higher grade of insulin resistance. Whether the immediate insulinogenic effect (ie, the postprandial peak in insulin secretion) of the habitual diet contributes in the long term to risk of chronic diseases in ways that were not represented by the biomarkers that we studied deserves further examination. Table 2 (model 2). P = 0.27 for the interaction between BMI and the dietary insulin index. 1 Percentage difference (95% CI) in triglycerides between highest and lowest quintiles of insulin index.
